Financial Comparison: Beauty Health (NASDAQ:SKIN) versus Haleon (NYSE:HLN)

Haleon (NYSE:HLNGet Free Report) and Beauty Health (NASDAQ:SKINGet Free Report) are both consumer staples companies, but which is the better investment? We will contrast the two businesses based on the strength of their analyst recommendations, earnings, risk, dividends, profitability, institutional ownership and valuation.

Valuation and Earnings

This table compares Haleon and Beauty Health”s gross revenue, earnings per share and valuation.

Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
Haleon $14.54 billion 3.01 $2.20 billion $0.39 25.49
Beauty Health $300.80 million 0.28 -$9.52 million ($0.22) -2.91

Haleon has higher revenue and earnings than Beauty Health. Beauty Health is trading at a lower price-to-earnings ratio than Haleon, indicating that it is currently the more affordable of the two stocks.

Analyst Ratings

This is a summary of recent ratings and recommmendations for Haleon and Beauty Health, as reported by MarketBeat.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Haleon 2 3 3 2 2.50
Beauty Health 1 5 1 0 2.00

Beauty Health has a consensus price target of $1.52, suggesting a potential upside of 138.28%. Given Beauty Health’s higher possible upside, analysts plainly believe Beauty Health is more favorable than Haleon.

Profitability

This table compares Haleon and Beauty Health’s net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
Haleon N/A N/A N/A
Beauty Health -9.79% -47.83% -5.79%

Institutional & Insider Ownership

6.7% of Haleon shares are held by institutional investors. Comparatively, 93.3% of Beauty Health shares are held by institutional investors. 40.3% of Beauty Health shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term.

Volatility & Risk

Haleon has a beta of 0.12, meaning that its share price is 88% less volatile than the S&P 500. Comparatively, Beauty Health has a beta of 1.07, meaning that its share price is 7% more volatile than the S&P 500.

Summary

Haleon beats Beauty Health on 11 of the 15 factors compared between the two stocks.

About Haleon

(Get Free Report)

Haleon plc, together with its subsidiaries, engages in the research, development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company provides oral health products, such as toothpastes, mouth washes, and denture care products under the Sensodyne, Polident, Parodontax, Biotene brands; and vitamins, minerals, and supplements under Centrum, Emergen-C, Caltrate brands. It also offers various over-the-counter products comprising nasal drops, and cold, flu, and allergy relief products under Otrivine, Theraflu, and Flonase brands for respiratory issues; anti-inflammatory and pain relief products under Voltaren, Panadol, and Advil brands; and antacids and antihistamine products under TUMS, ENO, and Fenistil brands for digestive health and other issues. The company was formerly known as DRVW 2022 plc and changed its name to Haleon plc in February 2022. Haleon plc was founded in 1715 and is headquartered in Weybridge, the United Kingdom.

About Beauty Health

(Get Free Report)

The Beauty Health Company designs, develops, manufactures, markets, and sells aesthetic technologies and products worldwide. The company's flagship product includes HydraFacial that enhance the skin to cleanse, extract, and hydrate the skin with proprietary solutions and serums. Its products also comprise Syndeo, a Delivery System designs to connects providers to the consumer's preferences to create a more personalized experience; consumables, such as single-use tips, solutions, and serums used to provide a hydrafacial treatment; SkinStylus SteriLock Microsystem, a microneedling device used for the treatment of enhancing appearance of surgical or traumatic hypertrophic scars on the abdomen and facial acne scarring in Fitzpatrick skin types I, II, and III; and Keravive, a treatment for scalp health. The company was founded in 1997 and is headquartered in Long Beach, California.

Receive News & Ratings for Haleon Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Haleon and related companies with MarketBeat.com's FREE daily email newsletter.